These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

360 related items for PubMed ID: 11017830

  • 1. Cadaver donor screening for infectious agents in solid organ transplantation.
    Delmonico FL.
    Clin Infect Dis; 2000 Sep; 31(3):781-6. PubMed ID: 11017830
    [Abstract] [Full Text] [Related]

  • 2. Infections transmitted from donors to recipients following organ transplantation.
    Rao YG, Mirza DF.
    Natl Med J India; 2005 Sep; 18(4):189-94. PubMed ID: 16252549
    [Abstract] [Full Text] [Related]

  • 3. The high-risk donor: viral infections in solid organ transplantation.
    Singer AL, Kucirka LM, Namuyinga R, Hanrahan C, Subramanian AK, Segev DL.
    Curr Opin Organ Transplant; 2008 Aug; 13(4):400-4. PubMed ID: 18685336
    [Abstract] [Full Text] [Related]

  • 4. Impact of donor infections on outcome of orthotopic liver transplantation.
    Angelis M, Cooper JT, Freeman RB.
    Liver Transpl; 2003 May; 9(5):451-62. PubMed ID: 12740786
    [Abstract] [Full Text] [Related]

  • 5. The epidemiology and prevention of donor-derived infections.
    Ison MG.
    Adv Chronic Kidney Dis; 2009 Jul; 16(4):234-41. PubMed ID: 19576553
    [Abstract] [Full Text] [Related]

  • 6. Transplanting kidneys from donors with prior hepatitis B infection: one response to the organ shortage.
    Fabrizio F, Bunnapradist S, Martin P.
    J Nephrol; 2002 Jul; 15(6):605-13. PubMed ID: 12495272
    [Abstract] [Full Text] [Related]

  • 7. Infections transmitted by transplantation.
    Morris MI, Fischer SA, Ison MG.
    Infect Dis Clin North Am; 2010 Jun; 24(2):497-514. PubMed ID: 20466280
    [Abstract] [Full Text] [Related]

  • 8. Prevalence of skin allograft discards as a result of serological and molecular microbiological screening in a regional skin bank in Italy.
    Pianigiani E, Risulo M, Ierardi F, Sbano P, Andreassi L, Fimiani M, Caudai C, Valensin PE, Zazzi M.
    Burns; 2006 May; 32(3):348-51. PubMed ID: 16529868
    [Abstract] [Full Text] [Related]

  • 9. Role of nucleic acid testing in cadaver organ donor screening: detection of hepatitis C virus RNA in seropositive and seronegative donors.
    Aswad S, Khan NS, Comanor L, Chinchilla C, Corado L, Mone T, Mendez R, Mendez R.
    J Viral Hepat; 2005 Nov; 12(6):627-34. PubMed ID: 16255764
    [Abstract] [Full Text] [Related]

  • 10. Transplantation of high-risk donor organs: a survey of US solid organ transplant center practices as reported by transplant infectious diseases physicians.
    Ison MG, Stosor V.
    Clin Transplant; 2009 Nov; 23(6):866-73. PubMed ID: 19473202
    [Abstract] [Full Text] [Related]

  • 11. Risk of transmission of hepatitis B virus from anti-HBC positive cadaveric organ donors: a collaborative study.
    De Feo TM, Poli F, Mozzi F, Moretti MP, Scalamogna M, Collaborative Kidney, Liver and Heart North Italy Transplant Program Study Groups.
    Transplant Proc; 2005 Mar; 37(2):1238-9. PubMed ID: 15848681
    [Abstract] [Full Text] [Related]

  • 12. Successful solid organ transplantation from septicemic cadaveric donors: case report.
    Sözen H, Fidan K, Mahli A, Singin E, Buyan N, Sindel S, Söylemezoğlu O, Arinsoy T, Dalgic A.
    Transplant Proc; 2008 Mar; 40(1):299-301. PubMed ID: 18261610
    [Abstract] [Full Text] [Related]

  • 13. Hepatitis C virus transmission from an antibody-negative organ and tissue donor--United States, 2000-2002.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2003 Apr 04; 52(13):273-4, 276. PubMed ID: 12729075
    [Abstract] [Full Text] [Related]

  • 14. New technologies for infectious screening of organ donors.
    Fishman JA.
    Transplant Proc; 2011 Apr 04; 43(6):2443-5. PubMed ID: 21839288
    [Abstract] [Full Text] [Related]

  • 15. Annual literature review--clinical transplants 2000.
    Markmann JF, Campos L, Velidedeoglu E, Guy TS, Moainie SL, Desai NM, Gorman RC, Brayman KL, Naji A, Barker CF.
    Clin Transpl; 2000 Apr 04; ():411-65. PubMed ID: 11512357
    [No Abstract] [Full Text] [Related]

  • 16. HTLV-1 in solid-organ transplantation: current challenges and future management strategies.
    Armstrong MJ, Corbett C, Rowe IA, Taylor GP, Neuberger JM.
    Transplantation; 2012 Dec 15; 94(11):1075-84. PubMed ID: 23060278
    [Abstract] [Full Text] [Related]

  • 17. The transmission of hepatitis B by renal transplantation.
    Lutwick LI, Sywassink JM, Corry RJ, Shorey JW.
    Clin Nephrol; 1983 Jun 15; 19(6):317-9. PubMed ID: 6347491
    [Abstract] [Full Text] [Related]

  • 18. Donor derived malignancy following transplantation: a review.
    Gandhi MJ, Strong DM.
    Cell Tissue Bank; 2007 Jun 15; 8(4):267-86. PubMed ID: 17440834
    [Abstract] [Full Text] [Related]

  • 19. Donor screening for hepatitis B virus infection in a cell and tissue bank.
    Solves P, Mirabet V, Alvarez M, Vila E, Quiles F, Villalba JV, Montoro JA, Soler MA, Roig RJ.
    Transpl Infect Dis; 2008 Dec 15; 10(6):391-5. PubMed ID: 18665905
    [Abstract] [Full Text] [Related]

  • 20. Donor screening: an overview of current regulation and practices in Europe.
    Tjabbes H.
    Transplant Proc; 1996 Oct 15; 28(5):2950-2. PubMed ID: 8908136
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.